The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC).
 
Martin Chasen
No Relationships to Disclose
 
Laszlo Urban
No Relationships to Disclose
 
Ian Schnadig
Employment - Compass Oncology
Travel, Accommodations, Expenses - Tesaro
 
Bernardo Leon Rapoport
Consulting or Advisory Role - MSD; Tesaro
Speakers' Bureau - MSD; Roche Pharma AG
Travel, Accommodations, Expenses - MSD; Tesaro
 
Allen Poma
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Sujata Arora
Stock and Other Ownership Interests - Medtronic; Tesaro
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Rudolph M. Navari
No Relationships to Disclose
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Eisai; Genentech; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai
 
Cesare Gridelli
No Relationships to Disclose